Protara Therapeutics, Inc. Debt Issuance Costs, Gross
Protara Therapeutics, Inc. (TARA) had Debt Issuance Costs, Gross of $100.00 thousand as of 2015-12-31, per its 10-K filed 2016-03-14.
Discontinued › Notes › Debt
us-gaap:DeferredFinanceCostsGross · last filed 2016-03-14
- 2015-12-31: Debt Issuance Costs, Gross $100.00K.
- 2014-12-31: Debt Issuance Costs, Gross $18.00K.
- 2013-12-31: Debt Issuance Costs, Gross $18.00K.
- 2012-12-31: Debt Issuance Costs, Gross $0.00.
| Period end | Debt Issuance Costs, Gross |
|---|---|
| 2015-12-31 | $100.00K 10-K · filed 2016-03-14 |
| 2014-12-31 | $18.00K 10-K · filed 2015-03-20 |
| 2013-12-31 | $18.00K 10-K · filed 2015-03-20 |
| 2012-12-31 | $0.00 10-K · filed 2015-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |